Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes

Experimental Gerontology
Robert J ScheubelAndreas Simm

Abstract

Diabetes and ageing induce reduction and dysfunction of vascular progenitor cells. Advanced glycation endproducts (AGEs) accumulate in diabetes and ageing. We investigated the influence of AGEs on function of CD34 progenitor cells. CD34 cells were co-cultured with HUVECs in a three-dimensional spheroid assay. Sprout length growth and incorporation of CD34 cells into the sprouts were analyzed under 2, 20 or 200 microg/ml AGEs. AGE-receptor expression, MAP-kinase signal transduction and apoptosis were analyzed using PCR, Western blotting and flow cytometry. In the spheroid assay, AGEs concentration-dependently cause a reduction of sprout length growth by 6+/-6 to 32+/-6% and an attenuation of progenitor cells incorporation into the sprouting endothelium by up to 43+/-6%. This functional impairment is accompanied by activation of CD34 cell proliferation at lower concentrations (2 or 20 microg/ml) and by apoptosis activation under 200 microg/ml AGEs. The mRNA expression of the receptors for AGEs and the AGEs-induced activation of p38 and p44/42 MAP-kinases are demonstrable in CD34 cells. This AGEs-mediated impairment of progenitor cell function identifies a new pathophysiological mechanism of disturbed vascular adaptation in diabet...Continue Reading

Citations

Aug 21, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Xabier L ArangurenAernout Luttun
Feb 19, 2008·Cardiovascular Research·Gaia SpinettiPaolo Madeddu
Jul 13, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuan YingRui Y Zhang
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Andrey G Zenovich, Doris A Taylor
Apr 24, 2014·Journal of Clinical Medicine·Lisa B Boyette, Rocky S Tuan
Aug 9, 2011·Experimental Diabetes Research·Stella BernardiPaola Secchiero
Mar 4, 2014·Endocrinology and Metabolism Clinics of North America·Jason C KovacicValentin Fuster
Mar 29, 2011·Biochimica Et Biophysica Acta·Sho-ichi YamagishiSeiya Okuda
Sep 22, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·C ShenN Liu
Sep 4, 2008·Experimental Gerontology·Alexander Navarrete SantosAndreas Simm
Jul 23, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Xiaoling ZhangYing Xu
May 12, 2007·Atherosclerosis·Gian Paolo FadiniAngelo Avogaro
Mar 31, 2015·Mechanisms of Ageing and Development·Alexander BürkleRichard Aspinall
Nov 15, 2008·International Journal of Cardiology·Robert J ScheubelAndreas Simm
Mar 20, 2010·Circulation Research·Yagna P R Jarajapu, Maria B Grant
Nov 26, 2015·Molecular Medicine·Sho-Ichi YamagishiTakanori Matsui
Dec 25, 2009·Expert Review of Molecular Diagnostics·Carlo ForestaAntonella Di Mambro
Jan 1, 2010·Expert Review of Endocrinology & Metabolism·Ying ZhugeOmaida C Velazquez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis